We are live on ! Find out more
BCP

BlackBarn Capital Partners Portfolio holdings

AUM $1.19B
1-Year Est. Return 63.92%
This Fund
S&P 500
This Quarter Est. Return
+14.84%
1 Year Est. Return
+63.92%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.19B
AUM Growth
-$57.7M
Cap. Flow
+$37.1M
Cap. Flow %
3.13%
Top 10 Hldgs %
81.6%
Holding
30
New
9
Increased
3
Reduced
7
Closed
6

Sector Composition

Rank Sector Weight
1 Miscellaneous 69.27%
2 Healthcare 16.58%
3 Technology 4.42%
4 Energy 3.45%
5 Utilities 2.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$808B
$597M 50.4%
800,000
ROIV icon
2
Roivant Sciences
ROIV
$29.5B
$70.8M 5.97%
2,000,000
-285,117
-12% -$8.43M
OSCR icon
3
PUT
Oscar Health
OSCR
$10.1B
$49.9M 4.21%
+1,750,000
New +$37.7M
UNH icon
4
CALL
UnitedHealth
UNH
$340B
$41.6M 3.51%
+100,000
New +$37.1M
PRVA icon
5
Privia Health
PRVA
$2.61B
$40.8M 3.44%
1,585,000
RMD icon
6
PUT
ResMed
RMD
$31.5B
$39M 3.29%
200,000
-200,000
-50% -$41.5M
DHC
7
Diversified Healthcare Trust
DHC
$1.82B
$37.9M 3.2%
4,075,000
-737,413
-15% -$6.04M
VG
8
CALL
Venture Global Inc
VG
$39.5B
$33.4M 2.82%
+3,000,000
New +$38M
NEE icon
9
NextEra Energy
NEE
$172B
$29.4M 2.48%
335,000
NIQ
10
NIQ Global Intelligence PLC
NIQ
$5.26B
$27.2M 2.29%
2,903,862
+829,101
+40% +$8.02M
UNH icon
11
UnitedHealth
UNH
$340B
$27M 2.28%
+65,000
New +$24.1M
NXPI icon
12
NXP Semiconductors
NXPI
$59.7B
$25.3M 2.13%
90,000
+30,000
+50% +$8.27M
VKTX icon
13
Viking Therapeutics
VKTX
$3.73B
$23.4M 1.97%
600,000
-21,450
-3% -$693K
MH
14
McGraw Hill
MH
$2.36B
$23.2M 1.96%
2,450,000
+361,508
+17% +$4.36M
AMRX icon
15
Amneal Pharmaceuticals
AMRX
$5.92B
$22.5M 1.9%
1,300,000
-350,000
-21% -$4.8M
VG
16
Venture Global Inc
VG
$39.5B
$19.5M 1.64%
+1,750,000
New +$22.1M
AZUL
17
Azul S.A.
AZUL
$1.26B
$15.1M 1.28%
+1,684,188
New +$14.9M
OXY icon
18
Occidental Petroleum
OXY
$61.4B
$12.1M 1.02%
+250,000
New +$14.2M
WRBY icon
19
PUT
Warby Parker
WRBY
$3.05B
$12.1M 1.02%
400,000
-600,000
-60% -$14.9M
ABUS icon
20
Arbutus Biopharma
ABUS
$1.01B
$12M 1.01%
2,500,000
VKTX icon
21
CALL
Viking Therapeutics
VKTX
$3.73B
$9.75M 0.82%
+250,000
New +$8.08M
CRC icon
22
California Resources
CRC
$5.04B
$9.25M 0.78%
+175,000
New +$10.8M
CCOI icon
23
Cogent Communications
CCOI
$478M
$3.47M 0.29%
250,000
-250,000
-50% -$4.61M
SEAT icon
24
Vivid Seats
SEAT
$55.6M
$3.26M 0.28%
500,000
AAL icon
25
PUT
American Airlines Group
AAL
$8.61B
-4,000,000
Closed -$43M

Similar funds

BlackBarn Capital Partners's Q2 2026 Portfolio in Review

As of Q2 2026, BlackBarn Capital Partners held 30 positions worth $1.19B, down 4.6% from $1.24B the previous quarter. Its ten largest holdings account for 82% of the portfolio.

BlackBarn Capital Partners deployed $37.1M of net new capital in Q2 2026, opening 9 new positions and adding to 3 existing holdings. Its largest new stake was UnitedHealth: 65,000 shares worth $27M.

By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, down from 76% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Roivant Sciences, an estimated $8.43M trimmed.

  • BlackBarn Capital Partners's largest Q2 2026 buy was UnitedHealth: 65,000 shares worth $27M.
  • BlackBarn Capital Partners added most to NXP Semiconductors in Q2 2026, an estimated $8.27M increase.
  • BlackBarn Capital Partners's biggest Q2 2026 reduction was Roivant Sciences, cutting an estimated $8.43M.
  • BlackBarn Capital Partners fully exited Veeco in Q2 2026, selling an estimated $33.9M.
  • BlackBarn Capital Partners's ten largest holdings make up 82% of its $1.19B portfolio in Q2 2026.
  • BlackBarn Capital Partners opened 9 new positions and closed 6 in Q2 2026.
  • BlackBarn Capital Partners's portfolio value fell 4.6% quarter-over-quarter to $1.19B.

Based on BlackBarn Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.